跳至主要内容
临床试验/JPRN-UMIN000013375
JPRN-UMIN000013375招募中未知

Outcomes in chronic Kidney disease by purified Eicosapentaenoic acids for the prevention of HAZardous events:A Multicenter rAndomized control trial (OKEHAZAMA Trial) - The renoprotective effects of purified EPA in a population with chronic kidney disease

Fujita Health University School of Medicine0 个研究点目标入组 300 人开始时间: 2014年3月8日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Hypersensitivity to the study drug formulation 2.Cerebrovascular disorders occurring within last 6 months 3.Pregnant women 4.Hemorrage (hemophilia, capillary fragility, gastrointestinal ulcer, urinary tract hemorrhage, hemoptysis, vitreous hemorrhage, etc.) 5.Complication of active peptic ulcer disease, 6.Complication of serious hepatic disease 7.Complication of malignancy 8.Patients judged to be inappropriate by the physician in charge

研究者

发起方
Fujita Health University School of Medicine

相似试验